0
Skip to Content
Gadolinium 64
Letters
Letter to RFK Jr.
2020 Letter to FDA
2012 Letter to FDA
About Gd
What is Gadolinium?
Lead vs. Gad
Diseases
Test & Autopsy Results
Reasons for Underrecognition
Common Misconceptions
Scientific Literature
Advocacy
History of Harm
Timeline
Medwatch / FAERS
FDA Hearing
Warnings - CDC
Misleading Drug Application
Ponzi Scheme Article
CHD & 3 Letter Agencies
Industry Admissions
GadoliniumToxicity.com
MriDye.com
GBCA Deep Dive + Bans
Global Fibrosis
GBCA Forms
Media
Articles & Podcasts
Recent Newscasts
Gena and Chuck Norris
Interviews
Marcie Jacobs
Older Newscasts
Patients
Patient Video
Parents
Patient Stories
Jose
Kate
Marie Noël
Kunal
Catherine
Naejomi
Debbie
Erin
Physicians
List of Providers
Dr. Brent Wagner, MD
Dr. Richard Semelka, MD
Dr. Catriona Walsh, MB & Gd Patient
Support Us
Goals
Donate
Contact Us
Sign the Petition
Make FDA Report
Gadolinium 64
Letters
Letter to RFK Jr.
2020 Letter to FDA
2012 Letter to FDA
About Gd
What is Gadolinium?
Lead vs. Gad
Diseases
Test & Autopsy Results
Reasons for Underrecognition
Common Misconceptions
Scientific Literature
Advocacy
History of Harm
Timeline
Medwatch / FAERS
FDA Hearing
Warnings - CDC
Misleading Drug Application
Ponzi Scheme Article
CHD & 3 Letter Agencies
Industry Admissions
GadoliniumToxicity.com
MriDye.com
GBCA Deep Dive + Bans
Global Fibrosis
GBCA Forms
Media
Articles & Podcasts
Recent Newscasts
Gena and Chuck Norris
Interviews
Marcie Jacobs
Older Newscasts
Patients
Patient Video
Parents
Patient Stories
Jose
Kate
Marie Noël
Kunal
Catherine
Naejomi
Debbie
Erin
Physicians
List of Providers
Dr. Brent Wagner, MD
Dr. Richard Semelka, MD
Dr. Catriona Walsh, MB & Gd Patient
Support Us
Goals
Donate
Contact Us
Sign the Petition
Make FDA Report
Folder: Letters
Back
Letter to RFK Jr.
2020 Letter to FDA
2012 Letter to FDA
Folder: About Gd
Back
What is Gadolinium?
Lead vs. Gad
Diseases
Test & Autopsy Results
Reasons for Underrecognition
Common Misconceptions
Scientific Literature
Advocacy
Folder: History of Harm
Back
Timeline
Medwatch / FAERS
FDA Hearing
Warnings - CDC
Misleading Drug Application
Ponzi Scheme Article
CHD & 3 Letter Agencies
Industry Admissions
GadoliniumToxicity.com
MriDye.com
GBCA Deep Dive + Bans
Global Fibrosis
GBCA Forms
Folder: Media
Back
Articles & Podcasts
Recent Newscasts
Gena and Chuck Norris
Interviews
Marcie Jacobs
Older Newscasts
Folder: Patients
Back
Patient Video
Parents
Patient Stories
Jose
Kate
Marie Noël
Kunal
Catherine
Naejomi
Debbie
Erin
Folder: Physicians
Back
List of Providers
Dr. Brent Wagner, MD
Dr. Richard Semelka, MD
Dr. Catriona Walsh, MB & Gd Patient
Folder: Support Us
Back
Goals
Donate
Contact Us
Sign the Petition
Make FDA Report

Categories: All Articles • Nanoparticles • Dechelation • Cellular + Mito Dysfunction • GDD/Toxicity • Fibrosis • Other Disease • Chemistry • Heavy Metal Toxicity • Treatment Options • Water Contamination • Other Gd Uses • Pediatrics • Chelators

The Effect of Perinatal Gadolinium-Based Contrast Agents on Adult Mice Behavior
Bridget Belo 2/1/18 Bridget Belo 2/1/18

The Effect of Perinatal Gadolinium-Based Contrast Agents on Adult Mice Behavior

Read More
Biological effects of MRI contrast agents: gadolinium retention, potential mechanisms and a role for phosphorus (October 2017).
Editor's Choice Bridget Belo 8/30/17 Editor's Choice Bridget Belo 8/30/17

Biological effects of MRI contrast agents: gadolinium retention, potential mechanisms and a role for phosphorus (October 2017).

Read More
“Gadolinium Speciation” Presentation
Dechelation, chelator Bridget Belo 1/1/17 Dechelation, chelator Bridget Belo 1/1/17

“Gadolinium Speciation” Presentation

Read More
Association Between MRI Exposure During Pregnancy and Fetal and Childhood Outcomes (Sept 2016).
Kate 9/6/16 Kate 9/6/16

Association Between MRI Exposure During Pregnancy and Fetal and Childhood Outcomes (Sept 2016).

Read More
Gadolinium toxicity: Iron and ferroportin as central targets (2016).
Kate 8/28/16 Kate 8/28/16

Gadolinium toxicity: Iron and ferroportin as central targets (2016).

Read More
Pathophysiology of gadolinium-associated systemic fibrosis (2016).
Fibrosis Kate 7/1/16 Fibrosis Kate 7/1/16

Pathophysiology of gadolinium-associated systemic fibrosis (2016).

Read More
Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms (2016).
Kate 4/6/16 Kate 4/6/16

Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms (2016).

Read More
High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material (2014).
GDD/Toxicity Bridget Belo 12/7/13 GDD/Toxicity Bridget Belo 12/7/13

High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material (2014).

Read More
Encyclopedia of Metalloproteins: Lanthanide/Actinide in Health and Disease (2013).
Bridget Belo 5/1/13 Bridget Belo 5/1/13

Encyclopedia of Metalloproteins: Lanthanide/Actinide in Health and Disease (2013).

Read More
Toxic effects of mercury, lead and gadolinium on vascular reactivity (2011).
GDD/Toxicity, Heavy Metal Toxicity, Chemistry Kate 9/1/11 GDD/Toxicity, Heavy Metal Toxicity, Chemistry Kate 9/1/11

Toxic effects of mercury, lead and gadolinium on vascular reactivity (2011).

Read More
Gadolinium-promoted precipitation of calcium phosphate is associated with profibrotic activation of RAW 264.7 macrophages (2010).
Bridget Belo 9/1/10 Bridget Belo 9/1/10

Gadolinium-promoted precipitation of calcium phosphate is associated with profibrotic activation of RAW 264.7 macrophages (2010).

Read More
Gadolinium-Containing Contrast Agent Promotes Multiple Myeloma Cell Growth: Implication for Clinical Use of MRI in Myeloma (2009).
Other Disease, GDD/Toxicity, Cellular Kate 11/20/09 Other Disease, GDD/Toxicity, Cellular Kate 11/20/09

Gadolinium-Containing Contrast Agent Promotes Multiple Myeloma Cell Growth: Implication for Clinical Use of MRI in Myeloma (2009).

Read More
Neurotoxic Effects of Gadopentetate Dimeglumine: Behavioral Disturbance and Morphology after Intracerebroventricular Injection in Rats—Gd induces brain lesions, MS patients beware (1996).
GDD/Toxicity, Other Disease Bridget Belo 2/1/96 GDD/Toxicity, Other Disease Bridget Belo 2/1/96

Neurotoxic Effects of Gadopentetate Dimeglumine: Behavioral Disturbance and Morphology after Intracerebroventricular Injection in Rats—Gd induces brain lesions, MS patients beware (1996).

Read More
TOXICOLOGICAL AND PHARMACOLOGICAL EFFECTS OFGADOLINIUM- AND SAMARIUM CHLORIDES (1961).
Kate 1/1/70 Kate 1/1/70

TOXICOLOGICAL AND PHARMACOLOGICAL EFFECTS OFGADOLINIUM- AND SAMARIUM CHLORIDES (1961).

Read More
Reversible Myocarditis Due to Chronic Lead Poisoning in Childhood (1965).
Treatment Options, Heavy Metal Toxicity Kate 1/1/70 Treatment Options, Heavy Metal Toxicity Kate 1/1/70

Reversible Myocarditis Due to Chronic Lead Poisoning in Childhood (1965).

Read More
Newer Posts

Submit any resources that should be included on the site.

Explore Gadolinium 64

Physicians

Donate

This site is also accessible via contrastdie.com
 
Fair Use Disclaimer
This website features copyrighted material used in accordance with the principles of fair use as outlined in Section 107 of the U.S. Copyright Act. The material is provided to inform, educate, and encourage public discussion on important issues, including health, education, and science. All content is shared with the intent of advancing understanding and fostering meaningful dialogue. This use is non-commercial and aligns with fair use standards for purposes such as research, education, and commentary. If you believe any content on this site infringes on your copyright, please contact us at Contact Us and we will review your concerns promptly.